Home Blog Page 129

Blog

Pharma Marketing Blog

Most popular

WLF: A No-Risk Ad is a Good Ad

Pharma Guy - August 15, 2006

Sales Rep “Free Speech” Does Not Include Important Safety Information: I...

Pharma Guy - April 10, 2013

Physician Education vs. Promotion

Pharma Guy - July 15, 2005

J&J Is Now Top-Fined Company in the Pharma Criminal & Civil...

Pharma Guy - November 13, 2013

You Might Be A Pharma Social Media Pioneer If…

Pharma Guy - September 30, 2013

Google Pharmacy Phish

Pharma Guy - March 2, 2012

Professional “Hired Gun” Pharma Tweeters. Is It a Good Idea?

Pharma Guy - July 26, 2010

J&J Lawyers Go Wild; PR on Vacation!

Pharma Guy - August 10, 2007

The History of Women in Healthcare

Claudia Barbiero - May 3, 2023

Pharma “Social Networks”: Close But No Cigar Award

Pharma Guy - April 20, 2010

1...128129130...240 Page 129 of 240

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

Researcher analyzing genetic data for an ultra-rare disease alongside physicians, DNA imagery, and patient silhouettes representing rare disease awareness and patient identification.

How Do You Market a Disease That Doesn’t Officially Exist?

August 6, 2026

Healthcare professional reviewing a plain-language clinical trial summary with a patient, illustrating how transparent communication strengthens trust, patient engagement, and pharmaceutical marketing.

The Plain-Language Revolution: How Compliance Is Becoming a Marketing Advantage

August 5, 2026

Healthcare professional reviewing a personalized medication dosing plan, illustrating flexible dosing strategies that support patient persistence and individualized treatment.

Could Flexible Dosing Become Pharma’s Next Competitive Advantage?

August 4, 2026